Market Overview:
Prochlorperazine maleate is an antipsychotic medication used to treat schizophrenia, psychosis caused by medical illness or drugs, and to control severe nausea and vomiting. It works by blocking dopamine receptors in the brain. Prochlorperazine maleate is available in oral tablet, suppository and injectable forms. It is very effective in treating nausea, vomiting and dizziness associated with motion sickness.

Market key trends:
Increasing prevalence of schizophrenia and motion sickness is estimated to drive the growth of prochlorperazine maleate market. Schizophrenia is a chronic, severe mental disorder that affects how a person thinks, feels, and behaves. WHO estimates around 21 million people worldwide have some form of schizophrenia. Rising cases of schizophrenia will increase the demand for prochlorperazine maleate which is widely used as antipsychotic medication. Prochlorperazine maleate drugs are also commonly prescribed to treat nausea and vomiting associated with motion sickness. According to some estimates, around 60% to 70% of the population experiences motion sickness under certain conditions. Growing number of people traveling via road, rail, air or sea will propel the demand for anti-motion sickness drugs like prochlorperazine maleate.

Key Takeaways
The global Prochlorperazine Maleate Market Size is expected to witness high growth, exhibiting CAGR of 3.5% over the forecast period, due to growing geriatric population suffering from psychosis and nausea. North America currently dominates the market and is expected to continue its dominance in the coming years owing to presence of major players and rising awareness.

Read More: https://newsinsights123.blogspot.com/2023/11/prochlorperazine-maleate-market-is.html